Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutations
BACKGROUND: Pathological forms of TAR DNA-binding protein 43 (TDP-43) are present in motor neurons of almost all amyotrophic lateral sclerosis (ALS) patients, and mutations in TDP-43 are also present in ALS. Loss and gain of TDP-43 functions are implicated in pathogenesis, but the mechanisms are unclear. While the RNA functions of TDP-43 have been widely investigated, its DNA binding roles remain unclear. However, recent studies have implicated a role for TDP-43 in the DNA damage response.
METHODS: We used NSC-34 motor neuron-like cells and primary cortical neurons expressing wildtype TDP-43 or TDP-43 ALS associated mutants (A315T, Q331K), in which DNA damage was induced by etoposide or H2O2 treatment. We investigated the consequences of depletion of TDP-43 on DNA repair using small interfering RNAs. Specific non homologous end joining (NHEJ) reporters (EJ5GFP and EJ2GFP) and cells lacking DNA-dependent serine/threonine protein kinase (DNA-PK) were used to investigate the role of TDP-43 in DNA repair. To investigate the recruitment of TDP-43 to sites of DNA damage we used single molecule super-resolution microscopy and a co-immunoprecipitation assay. We also investigated DNA damage in an ALS transgenic mouse model, in which TDP-43 accumulates pathologically in the cytoplasm. We also examined fibroblasts derived from ALS patients bearing the TDP-43 M337V mutation for evidence of DNA damage.
RESULTS: We demonstrate that wildtype TDP-43 is recruited to sites of DNA damage where it participates in classical NHEJ DNA repair. However, ALS-associated TDP-43 mutants lose this activity, which induces DNA damage. Furthermore, DNA damage is present in mice displaying TDP-43 pathology, implying an active role in neurodegeneration. Additionally, DNA damage triggers features typical of TDP-43 pathology; cytoplasmic mis-localisation and stress granule formation. Similarly, inhibition of NHEJ induces TDP-43 mis-localisation to the cytoplasm.
CONCLUSIONS: This study reveals that TDP-43 functions in DNA repair, but loss of this function triggers DNA damage and is associated with key pathological features of ALS.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
Molecular neurodegeneration - 15(2020), 1 vom: 09. Sept., Seite 51 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Konopka, Anna [VerfasserIn] |
---|
Links: |
---|
Themen: |
DNA damage |
---|
Anmerkungen: |
Date Completed 26.08.2021 Date Revised 26.08.2021 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s13024-020-00386-4 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM31479879X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM31479879X | ||
003 | DE-627 | ||
005 | 20231225153520.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s13024-020-00386-4 |2 doi | |
028 | 5 | 2 | |a pubmed24n1049.xml |
035 | |a (DE-627)NLM31479879X | ||
035 | |a (NLM)32907630 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Konopka, Anna |e verfasserin |4 aut | |
245 | 1 | 0 | |a Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutations |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.08.2021 | ||
500 | |a Date Revised 26.08.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Pathological forms of TAR DNA-binding protein 43 (TDP-43) are present in motor neurons of almost all amyotrophic lateral sclerosis (ALS) patients, and mutations in TDP-43 are also present in ALS. Loss and gain of TDP-43 functions are implicated in pathogenesis, but the mechanisms are unclear. While the RNA functions of TDP-43 have been widely investigated, its DNA binding roles remain unclear. However, recent studies have implicated a role for TDP-43 in the DNA damage response | ||
520 | |a METHODS: We used NSC-34 motor neuron-like cells and primary cortical neurons expressing wildtype TDP-43 or TDP-43 ALS associated mutants (A315T, Q331K), in which DNA damage was induced by etoposide or H2O2 treatment. We investigated the consequences of depletion of TDP-43 on DNA repair using small interfering RNAs. Specific non homologous end joining (NHEJ) reporters (EJ5GFP and EJ2GFP) and cells lacking DNA-dependent serine/threonine protein kinase (DNA-PK) were used to investigate the role of TDP-43 in DNA repair. To investigate the recruitment of TDP-43 to sites of DNA damage we used single molecule super-resolution microscopy and a co-immunoprecipitation assay. We also investigated DNA damage in an ALS transgenic mouse model, in which TDP-43 accumulates pathologically in the cytoplasm. We also examined fibroblasts derived from ALS patients bearing the TDP-43 M337V mutation for evidence of DNA damage | ||
520 | |a RESULTS: We demonstrate that wildtype TDP-43 is recruited to sites of DNA damage where it participates in classical NHEJ DNA repair. However, ALS-associated TDP-43 mutants lose this activity, which induces DNA damage. Furthermore, DNA damage is present in mice displaying TDP-43 pathology, implying an active role in neurodegeneration. Additionally, DNA damage triggers features typical of TDP-43 pathology; cytoplasmic mis-localisation and stress granule formation. Similarly, inhibition of NHEJ induces TDP-43 mis-localisation to the cytoplasm | ||
520 | |a CONCLUSIONS: This study reveals that TDP-43 functions in DNA repair, but loss of this function triggers DNA damage and is associated with key pathological features of ALS | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a DNA damage | |
650 | 4 | |a NHEJ | |
650 | 4 | |a Super-resolution microscopy | |
650 | 4 | |a TDP-43 mutations | |
650 | 7 | |a DNA-Binding Proteins |2 NLM | |
650 | 7 | |a TARDBP protein, human |2 NLM | |
650 | 7 | |a TDP-43 protein, mouse |2 NLM | |
700 | 1 | |a Whelan, Donna R |e verfasserin |4 aut | |
700 | 1 | |a Jamali, Md Shafi |e verfasserin |4 aut | |
700 | 1 | |a Perri, Emma |e verfasserin |4 aut | |
700 | 1 | |a Shahheydari, Hamideh |e verfasserin |4 aut | |
700 | 1 | |a Toth, Reka P |e verfasserin |4 aut | |
700 | 1 | |a Parakh, Sonam |e verfasserin |4 aut | |
700 | 1 | |a Robinson, Tina |e verfasserin |4 aut | |
700 | 1 | |a Cheong, Alison |e verfasserin |4 aut | |
700 | 1 | |a Mehta, Prachi |e verfasserin |4 aut | |
700 | 1 | |a Vidal, Marta |e verfasserin |4 aut | |
700 | 1 | |a Ragagnin, Audrey M G |e verfasserin |4 aut | |
700 | 1 | |a Khizhnyak, Ivan |e verfasserin |4 aut | |
700 | 1 | |a Jagaraj, Cyril J |e verfasserin |4 aut | |
700 | 1 | |a Galper, Jasmin |e verfasserin |4 aut | |
700 | 1 | |a Grima, Natalie |e verfasserin |4 aut | |
700 | 1 | |a Deva, Anand |e verfasserin |4 aut | |
700 | 1 | |a Shadfar, Sina |e verfasserin |4 aut | |
700 | 1 | |a Nicholson, Garth A |e verfasserin |4 aut | |
700 | 1 | |a Yang, Shu |e verfasserin |4 aut | |
700 | 1 | |a Cutts, Suzanne M |e verfasserin |4 aut | |
700 | 1 | |a Horejsi, Zuzana |e verfasserin |4 aut | |
700 | 1 | |a Bell, Toby D M |e verfasserin |4 aut | |
700 | 1 | |a Walker, Adam K |e verfasserin |4 aut | |
700 | 1 | |a Blair, Ian P |e verfasserin |4 aut | |
700 | 1 | |a Atkin, Julie D |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Molecular neurodegeneration |d 2006 |g 15(2020), 1 vom: 09. Sept., Seite 51 |w (DE-627)NLM164980016 |x 1750-1326 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2020 |g number:1 |g day:09 |g month:09 |g pages:51 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13024-020-00386-4 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2020 |e 1 |b 09 |c 09 |h 51 |